skip to main content

Chemistry, part 1

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > tertiary amino compound > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > tertiary amino compound > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > tertiary amino compound > n-arylpiperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > tertiary amino compound > n-arylpiperazine > dasatinib (anhydrous)
organic aromatic compound > aromatic amine > n-arylpiperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > aromatic amine > n-arylpiperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > aromatic amine > n-arylpiperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > tertiary amino compound > n-alkylpiperazine > n-(2-hydroxyethyl)piperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > tertiary amino compound > n-alkylpiperazine > n-(2-hydroxyethyl)piperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > amino alcohol > ethanolamines > n-(2-hydroxyethyl)piperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > amino alcohol > ethanolamines > n-(2-hydroxyethyl)piperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic hydroxy compound > alcohol > amino alcohol > ethanolamines > n-(2-hydroxyethyl)piperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > hydroxides > organic hydroxy compound > alcohol > amino alcohol > ethanolamines > n-(2-hydroxyethyl)piperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > s-block molecular entity > hydrogen molecular entity > hydroxides > organic hydroxy compound > alcohol > amino alcohol > ethanolamines > n-(2-hydroxyethyl)piperazine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > aminopyrimidine > dasatinib (anhydrous)
... > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > aminopyrimidine > dasatinib (anhydrous)
... > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > aminopyrimidine > dasatinib (anhydrous)
organic aromatic compound > aromatic amine > aminopyrimidine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > aromatic amine > aminopyrimidine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > aromatic amine > aminopyrimidine > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > monocarboxylic acid amide > dasatinib (anhydrous)
organooxygen compound > carboxamide > monocarboxylic acid amide > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > monocarboxylic acid amide > dasatinib (anhydrous)
organochlorine compound > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > organosulfur heterocyclic compound > thiazoles > 1,3-thiazoles > dasatinib (anhydrous)
organic heterocyclic compound > organosulfur heterocyclic compound > thiazoles > 1,3-thiazoles > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > azole > thiazoles > 1,3-thiazoles > dasatinib (anhydrous)
... > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > thiazoles > 1,3-thiazoles > dasatinib (anhydrous)
... > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > thiazoles > 1,3-thiazoles > dasatinib (anhydrous)
... > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > thiazoles > 1,3-thiazoles > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > secondary amino compound > dasatinib (anhydrous)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > secondary amino compound > dasatinib (anhydrous)

Preferred term

dasatinib (anhydrous)  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

alt_id

  • CHEBI:38943
  • CHEBI:49372

charge

  • 0

formula

  • C22H26ClN7O2S

has_role

inchi

  • InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)

inchikey

  • ZBNZXTGUTAYRHI-UHFFFAOYSA-N

is_conjugate_base_of

mass

  • 488.00652

monoisotopicmass

  • 487.15572

smiles

  • Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1

subset

  • 3_STAR

synonym EXACT

  • N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide

synonym RELATED

  • anh. dasatinib
  • anhydrous dasatinib
  • BMS-354825
  • BMS Dasatinib
  • dasatinib
  • dasatinib (anh.)
  • dasatinibum
  • N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:49375

Download this concept:

RDF/XML TURTLE JSON-LD